Recently, Kumagai et al. pointed out the clinicopathological significances of FXR expression in hepatic cell carcinoma (HCC) patients, and further indicated that enhanced expression of FXR in HCC had a close association with both proliferative activity and therapeutic modality49. Here, NR1H4 is linked to hepatocellular carcinoma.